Multiple Sclerosis

Dr Patricia Coyle Underscores the Importance of Diagnosing and Treating MS Early

September 18, 2020

Emerging data is showing that treatment within 6 months of presentation of multiple sclerosis (MS) is ideal, explained Patricia K. Coyle, MD, of Stony Brook University Neurosciences Institute.

Combined Training Program Improves Balance, Static Strength in Patients With MS

September 11, 2020

Results of a combined training program in 17 patients with multiple sclerosis indicate patients reap benefits from daily activities like walking or sitting-to-standing, and show the program reduces the dual-task cost of performing cognitive tasks while walking.

Case Study Highlights Possible Relationship Between MS, IBD

September 05, 2020

The authors suggest that recognizing the possible link may help identify patients at greater risk, although they do caution that larger studies are needed.

Engineered Gloves Show Promise at Measuring MS Limb Disability

September 04, 2020

A small study says that gloves with sensors could measure impairments in hand function and may have advantages over standard methods.

Patients, Physicians Largely Agree on Presence of MS Relapse, Analysis Finds

August 29, 2020

Patients were more likely to report more relapses of multiple sclerosis than physicians.

European Study Finds Patients With MS Adhere Better to Oral Therapies

August 23, 2020

Adherence to multiple sclerosis (MS) therapy is linked with improved clinical outcomes, better quality of life, lower health care costs, and other benefits.

FDA Approves Ofatumumab for Relapsing MS

August 21, 2020

For multiple sclerosis, the therapy will be sold as Kesimpta by Novartis; it is administered by patients once a month through the Sensoready autoinjector pen.

THC, CBD Combo Eases MS Symptoms, Extends Cutaneous Silent Period

August 20, 2020

A combination of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) relieved certain neurophysiological symptoms affecting patients with secondary progressive multiple sclerosis (MS).

Which Factors of MS Treatment Satisfaction Have Strongest Effect on HRQOL?

August 15, 2020

Certain aspects of satisfaction with multiple sclerosis (MS) treatment can impact health-related quality of life (HRQOL).

Measuring Gray Matter in the Brain to Predict MS Decline

August 14, 2020

The thalamus is among the first brain areas to atrophy in multiple sclerosis (MS); this study wanted to know if measuring this loss can predict future disability.